news.cmlviz.com
menu
share

Option Market Alert: Accelerate Diagnostics Inc Implied Price Swing Hits An Elevated Level




Accelerate Diagnostics Inc (NASDAQ:AXDX) Risk Hits An Elevated Level

Date Published:

No Risk Alert Here: Before we dive into any analysis we simply note that Accelerate Diagnostics Inc (NASDAQ:AXDX) risk is neither elevated nor depressed. We'll detail it below -- but that's the lede -- the option market is in a holding period with an IV30 of 54.4% verus the IV30 of the S&P 500 at 11.15%. You might say that the post it note for Accelerate Diagnostics Inc would read, "holding pattern." The annual high for Accelerate Diagnostics Inc IV30 is 148.37%.



To skip ahead and see if buying or selling options has been a winner in Accelerate Diagnostics Inc, you can go here: Geting serious about option trading.

PREFACE
This is a proprietary risk rating and risk alert system that looks forward for the next month -- or really 30 days to be exact -- and that includes weekends. The system is based on multiple interactions of data points, many of which come directly from the option market for Accelerate Diagnostics Inc (NASDAQ:AXDX) . The creator of this model is Capital Market Laboratories (CMLviz.com).


Option trading isn't about luck -- this three minute video will change your trading life forever: Option Trading and Truth


In the "Why This Matters" section at the end of this article on Accelerate Diagnostics Inc we're going to take a step back and show in great specificity that there is actually a lot less "luck" in successful option trading than many people know. The whole concept of an "option trading expert" is vastly over complicated and we'll talk about how superior returns are earned.

But first, let's turn back to AXDX and the company's risk rating:

We also take a peek at the implied vol for the Health Care ETF (XLV), our broad based proxy for AXDX.





SNAPSHOT SUMMARY
S&P 500 IV30     11.15%
Nasdaq 100 IV30     12.44%
XLV IV30     11.89%

AXDX HV 30     39.16%
AXDX Current IV30     54.4%
52 Week Low IV30     44.88%
52 Week High IV30     148.37%


The implied price swing risk as reflected by the option market has hit an elevated level relative to the company's past. The option market reflects a 95% confidence interval stock price range of ($21.80, $27.90) within the next 30 calendar days.

AXDX OPTION MARKET IMPLIED PRICE SWING RISK
The IV30® is the implied price swing risk reflected by the option market in the stock price for the next 30 calendar days -- it's forward looking. Accelerate Diagnostics Inc shows an IV30 of 54.4%, which is an elevated level for the company relative to its past.

The option market for AXDX has shown an IV30 annual low of 44.9% and an annual high of 148.4%, meaning that AXDX is at the 9% percentile right now. Here's a table of the data before we dig into the implied price swing risk rating further.

AXDX
Current IV30    
AXDX
Low IV30    
AXDX
High IV30   
54.4% 44.9% 148.4%

The implied stock swing risk from the option market is extremeley tight in the next 30 calendar days for Accelerate Diagnostics Inc (NASDAQ:AXDX) relative to the average in the last year.
Further, if we look backwards, the stock has a realized 30-day historical volatility, called the HV30, of 39.16%.




We have an unusual situation now where the IV30 is extremely depressed relative to the past, but even with that risk pricing, the option market reflects the likelihood of more stock movement in the next 30-days than it has in the last 30-days. Let's turn to a chart to see what's going on.
 
Note how much higher the forward looking stock swing price risk for Accelerate Diagnostics Inc is priced (54.4%) compared to what happened just in the last 30-days (39.2%).

Accelerate Diagnostics Inc Risk Rating
The AXDX risk rating is at 3.5, where the rating goes from one (the lowest risk) to five (the highest risk). The driving factors for the 3.5 rating are:

The IV30 is below the 20th percentile.
The IV30 is above 50%.
The HV30 is below the 20th percentile.
The IV30 is above the HV30.
The stock has moved +21.5% over the last 3-months which does indicate some elevated risk.